openPR Logo
Press release

Pelvic Inflammatory Disease Market Trends and Growth Propellers 2025

07-14-2017 04:42 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Pelvic Inflammatory Disease Market Trends and Growth

Pelvic inflammatory disease is an infection in the female reproductive system that includes ovaries, fallopian tubes, uterus, and cervix. Pelvic inflammation is generally caused by a sexually transmitted infection, like gonorrhea and chlamydia. Between 10% to 20% of women with gonococcal infection and 20% to 40% of women with cervical chlamydial infection eventually develop pelvic inflammatory disease. Early diagnosis and treatment are believed to be key elements in the prevention of the condition. If pelvic inflammation is not treated it leads to long term, serious problems such as infertility, Ectopic pregnancy, and chronic pelvic pain. According to the American Congress of Obstetricians and Gynecologists, more than 1 million women each year are affected by pelvic inflammatory disease in the U.S. Pelvic inflammation is more common among younger women. In the U.S., the cost of treating pelvic inflammatory disease is approximately US$ 2,000 per patient. Women with pelvic inflammatory disease have a 20% chance of developing infertility from tubal scarring. Approximately 13% of women are infertile after a single episode of pelvic inflammatory disease, 25-35% after two episodes, and 50-75% after three or more episodes. The month of April is celebrated as Sexually Transmitted Infection (STI) Awareness month, a time to remind teens and adults of the dangers of STIs and ways to prevent them.

Read the Comprehensive Overview of Pelvic Inflammatory Disease Market: http://www.transparencymarketresearch.com/pelvic-inflammatory-disease-market.html

Driving factors such as growing adoption of early diagnosis procedures, changing lifestyles, rapid population growth, growing HIV population, and increasing antibiotics use will fuel the global pelvic inflammatory disease market. According to the U.S. Department of Health & Human Services, approximately 36.7 million people worldwide were living with HIV/AIDS at the end of 2015. Growing awareness among people, increasing research and development, and government initiatives are the other factors which will accelerate the overall pelvic inflammatory disease market growth. On the other hand, side effects of products and a competitive market place may hinder growth.

The pelvic inflammatory disease market has been segmented by disease type, product type, dosage form, distribution channel, and geography. In terms of disease type, the pelvic inflammatory disease market is classified into acute pelvic inflammatory disease, subacute pelvic inflammatory disease, chronic pelvic inflammatory disease, and sexually transmitted pelvic inflammatory disease. In terms of product type, the pelvic inflammatory disease market is classified into Macrolides, Cephalosporins, Tetracyclines, Aminoglycosides, and Others. In terms of dosage form, the market is segmented into parenteral, oral and intramuscular. In terms of distribution channel, the market is classified into hospitals, pharmacies, retail pharmacies, and online pharmacies.

Geographically, the pelvic inflammatory disease market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Geographically, North America dominates the pelvic inflammatory disease market. Pelvic inflammatory disease is a serious bacterial infection in the U.S., which affects nearly 1,000,000 women each year and 25% of women with pelvic inflammation must be admitted to the hospital for treatment. Europe is the second largest market for pelvic inflammatory disease. Asia Pacific is expected to expand at a higher rate due to rapid population growth, growing awareness among people, increasing healthcare expenditure, and government initiatives that will drive the pelvic inflammatory disease market in the region. Emerging regions such as Latin America and Middle East & Africa are likely to create ample opportunities for the global pelvic inflammatory disease market. According to Department of STD, AIDS and Viral Hepatitis, in 2015, Brazil had the record number of people undergoing treatment for HIV and AIDS. From 2009 to 2015, the total number of people being treated in the Brazilian Unified Health System (SUS) climbed by 97%, rising from 231 thousand to 455 thousand people.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26990

The major players operating in the pelvic inflammatory disease market include F. Hoffmann-La Roche Ltd, Sanofi S.A., Pfizer Inc., Hospira Inc., Teligent Inc., and GlaxoSmithKline LLC, apart from other significant players worldwide.

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pelvic Inflammatory Disease Market Trends and Growth Propellers 2025 here

News-ID: 625729 • Views: 167

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Pelvic

Female Pelvic Implants Market Competitive Environment and Forecast 2017 - 2025
Global Female Pelvic Implants Market: Snapshot Female pelvic in plants is a procedure which is used for treating stress urinary incontinence and pelvic organ prolapse. In the markets today, there are three main types of implants which are used for this procedure. They are, vaginal mesh implants, vaginal Graft in plants, and vaginal sling. Among these, it is the vagina slings which is expected to show promising growth in the years
Female Pelvic Implants Market - Product Diversification 2025 | Stryker, C.R. Bar …
Global Female Pelvic Implants Market: Snapshot Female pelvic in plants is a procedure which is used for treating stress urinary incontinence and pelvic organ prolapse. In the markets today, there are three main types of implants which are used for this procedure. They are, vaginal mesh implants, vaginal Graft in plants, and vaginal sling. Among these, it is the vagina slings which is expected to show promising growth in the years
Female Pelvic Implants Market Global Entry Strategies 2025
Global Female Pelvic Implants Market: Snapshot Female pelvic in plants is a procedure which is used for treating stress urinary incontinence and pelvic organ prolapse. In the markets today, there are three main types of implants which are used for this procedure. They are, vaginal mesh implants, vaginal Graft in plants, and vaginal sling. Among these, it is the vagina slings which is expected to show promising growth in the years
Global Pelvic Electro-stimulators Market Developments and Innovations 2018
Qyresearchreports include new market research report "Global Pelvic Electro-stimulators Market Professional Survey Report 2018" to its huge collection of research reports. A market intelligence report on the global market for Pelvic Electro-stimulators has been added to enable key stakeholders in it to bet right on the market and thus improve their profit margins. The exhaustive report furnishes information on how the market for Pelvic Electro-stimulators will evolve over the course of
Pelvic Floor Stimulation Therapy Market - Market Future Growth Opportunities | 2 …
Pelvic floor stimulation therapy market: Overview Pelvic floor stimulation (PFS) therapy is a nonsurgical process that activates the nerves and muscle mechanism of the pelvic floor. PFS therapy is frequently prescribed to strengthen the neuromuscular mechanism of the pelvic floor for the treatment of urinary incontinence. With the help of pelvic floor stimulation therapy, patients suffering from urinary incontinence can regain control over their bladder muscle and the muscles around
General and Pelvic Endoscopic Surgery Devices Market
ReportsWorldwide has announced the addition of a new report title General and Pelvic Endoscopic Surgery Devices Market to its growing collection of premium market research reports. This report provides an in-depth analysis of the global market for medical devices used in endoscopic general and pelvic surgeries. Medical devices covered in this report include: • access devices ¥ access site closure devices ¥ ancillary devices ¥ endoscopes ¥ hand instruments ¥ insufflation products For a Detailed description and table of contents of this report please